Caspar Stauffenberg studied Business Administration at the EPBS in Reutlingen and London. He joined Carlsquare in 2012 where he build up the Munich team and heads the Life Sciences sector. Before joining Carlsquare, he served as CEO of Aequos Endoprothetik GmbH, where he led the company through various financing rounds and then sold it to LIMA Corporate, a portfolio company of EQT. He was CFO of MAP Medizin Technologie GmbH before selling the company to ResMed and then CEO of ResMed Germany. He previously also worked as a project manager in the strategy and organization division of Arthur D. Little and as an M&A project manager at the Oetker Group.
Alle Artikel von Caspar Stauffenberg
Being an investment banker in M&A advisory can be exciting and rewarding, and the reward goes way beyond monetary aspects....